Beckmann Kerri R, Bennett Alice, Young Graeme P, Roder David M
School of Population Health, Facility of Health Sciences, University of Adelaide, Adelaide, Australia.
J Eval Clin Pract. 2014 Aug;20(4):467-77. doi: 10.1111/jep.12183. Epub 2014 May 22.
RATIONALE, AIMS AND OBJECTIVES: Population level data on colorectal cancer (CRC) management in Australia are lacking. This study assessed broad level patterns of care and concordance with guidelines for CRC management at the population level using linked administrative data from both the private and public health sectors across South Australia. Disparities in CRC treatment were also explored.
Linking information from the South Australian Cancer Registry, hospital separations, radiotherapy services and hospital-based cancer registry systems provided data on the socio-demographic, clinical and treatment characteristics for 4641 CRC patients, aged 50-79 years, diagnosed from 2003 to 2008. Factors associated with receiving site/stage-specific treatments (surgery, chemotherapy and radiotherapy) and overall concordance with treatment guidelines were identified using Poisson regression analysis.
About 83% of colon and 56% of rectal cancer patients received recommended treatment. Provision of neo-adjuvant/adjuvant therapies may be less than optimal. Radiotherapy was less likely among older patients (prevalence ratio 0.7, 95% confidence interval 0.5-0.8). Chemotherapy was less likely among older patients (0.7, 0.6-0.8), those with severe or multiple co-morbidities (0.8, 0.7-0.9), and those from rural areas (0.9, 0.8-1.0). Overall discordance with treatment guidelines was more likely among rectal cancer patients (3.0, 2.7-3.3), older patients (1.6, 1.4-1.8), those with multiple co-morbid conditions (1.3, 1.1-1.4), and those living in rural areas (1.2, 1.0-1.3).
Greater emphasis should be given to ensure CRC patients who may benefit from neo-adjuvant/adjuvant therapies have access to these treatments.
原理、目的和目标:澳大利亚缺乏关于结直肠癌(CRC)管理的人群水平数据。本研究利用南澳大利亚州私营和公共卫生部门的关联行政数据,评估了人群水平上CRC管理的广泛护理模式以及与指南的一致性。还探讨了CRC治疗中的差异。
将南澳大利亚癌症登记处、医院出院记录、放疗服务和基于医院的癌症登记系统的信息相链接,提供了2003年至2008年诊断的4641例年龄在50 - 79岁的CRC患者的社会人口统计学、临床和治疗特征数据。使用泊松回归分析确定与接受部位/阶段特异性治疗(手术、化疗和放疗)相关的因素以及与治疗指南的总体一致性。
约83%的结肠癌患者和56%的直肠癌患者接受了推荐治疗。新辅助/辅助治疗的提供可能不太理想。老年患者接受放疗的可能性较小(患病率比0.7,95%置信区间0.5 - 0.8)。老年患者接受化疗的可能性较小(0.7,0.6 - 0.8),患有严重或多种合并症的患者(0.8,0.7 - 0.9)以及农村地区的患者(0.9,0.8 - 1.0)。直肠癌患者(3.0,2.7 - 3.3)、老年患者(1.6,1.4 - 1.8)、患有多种合并症的患者(1.3,1.1 - 1.4)以及居住在农村地区的患者(1.2,1.0 - 1.3)与治疗指南的总体不一致性更高。
应更加重视确保可能从新辅助/辅助治疗中获益的CRC患者能够获得这些治疗。